Huntingtin anticorps (N-Term)
Aperçu rapide pour Huntingtin anticorps (N-Term) (ABIN4889208)
Antigène
Voir toutes Huntingtin (HTT) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Reacts with the human Huntingtin protein
-
Réactivité croisée
- Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Cross react with mouse and rat protein due to sequence homology.
-
Purification
- Purified (protein A)
-
Immunogène
- synthetic peptide derived from N terminal part of human Huntingtin
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Must be reconstituted in distilled water.
-
Concentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 24 months
-
-
- Huntingtin (HTT)
-
Autre désignation
- Huntingtin
-
Sujet
- Defects in HTT are the cause of Huntington disease (HD). HD is an autosomal dominant neurodegenerative disorder characterized by involuntary movements (chorea), general motor impairment, psychiatric disorders and dementia.
-
UniProt
- P42858
-
Pathways
- Signalisation PI3K-Akt, Hormone Transport, Transition Metal Ion Homeostasis, Tube Formation, Protein targeting to Nucleus, Dicarboxylic Acid Transport
Antigène
-